Remove Containment Remove Life Science Remove Marketing
article thumbnail

Attorney Tope Leyimu Discusses Proposed FDA ban on Hair Relaxer Products Containing Harmful Chemicals – Xtalks Life Science Podcast Ep. 137

XTalks

This episode features an interview with Attorney Temitope (Tope) Leyimu, a toxic exposure attorney at Motley Rice who is leading a lawsuit over hair relaxing products that contain harmful chemicals. The FDA recently issued a recommendation for the recall of chemical hair relaxers containing harmful chemicals.

article thumbnail

How diversity can help life sciences advance its lifesaving solutions

pharmaphorum

Paula Parfitt discusses the importance of workplace diversity and how life science companies can build a thriving, diverse workforce. The life sciences sector is an industry built on collaborative creativity and innovation, providing life saving solutions to some of modern science’s most important problems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leading pharmaceutical logistics and pharma supply chain companies

Pharmaceutical Technology

The growing need for better pharmaceutical logistics, the rising demand for fast-track support, as well as growing adoption of telematics in pharmaceutical logistics are some of the important factors that are expected to drive the pharmaceutical logistics market. Finding the top pharmaceutical logistics and pharma supply chain companies.

article thumbnail

Tiziana Life Sciences plc (“Tiziana” or the “Company”) – Tiziana Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission

The Pharma Data

27, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces that it has filed a “universal” shelf registration statement on Form F-3 (File No. capital markets.

article thumbnail

Polyrizon IPO Strengthens Momentum in Non-Invasive Drug Delivery Solutions

XTalks

per unit, included 958,903 units, each containing one ordinary share and three warrants to purchase additional shares at an exercise price of $4.38 Trading began on the Nasdaq Capital Market under the ticker “PLRZ” on October 29, 2024. Polyrizon Ltd., million in gross proceeds. The IPO, priced at $4.38 Polyrizon Ltd.

article thumbnail

Protecting the supply chain: Why biopharma needs integrated workflows

Pharmaceutical Technology

Forecasting, planning, procurement, stock levels, and marketing strategies are some of the areas that managers look at to overcome challenges with biopharmaceutical supply chains, and new innovations in the industry are revolutionising production methods.

Packaging 130
article thumbnail

Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease

The Pharma Data

Crohn’s Disease Therapeutics Market Size $4.7 Weiner, chairman of the scientific advisory board of Tiziana Life Sciences, commented: “We understand that this will be the first-ever study with ‘take-home’ capsules of any mAb for immunotherapies for human diseases. The CD therapeutic market size will be worth $4.7